ERBB2 and breast carcinoma: This review will focus on the clinical presentation and diagnosis of brain metastases in HER2-positive breast cancer patients, a review of significant clinical trials that affect management decisions, and treatment with local and/or systemic therapy with anti-HER2-directed agents, as well as prognosis and future directions in this evolving area of treatment of this cohort of patients.